- Swingly
- Posts
- Pharma & Biotech: The Next Rotation..
Pharma & Biotech: The Next Rotation..

MARKET ANALYSIS
Here’s All You Need To Know

Change 1D, %
Today’s setup is far more important than the headline futures move suggests.
The biggest development is the sharp breakdown in crypto. Bitcoin is trading near $62,300, down around 3%, while Ethereum is trading near $1,660, down around 6.5%. That is a serious move lower in two of the highest-beta liquidity assets in the market.

BTCUSD VRVP Weekly & Monthly Chart

ETHUSD VRVP Weekly & Monthly Chart
This matters because BTC and ETH have been moving closely with the broader U.S. equity risk trade. When crypto breaks down this aggressively while equities are sitting near record highs, we need to pay attention.
The strange part is that the ETF data actually improved. Spot Bitcoin ETFs saw $3.05M of net inflows, ending a 13-day outflow streak. Spot Ethereum ETFs saw $19.3M of net inflows, ending a 17-day outflow streak.
On the surface, that sounds constructive. But underneath the surface, the crypto-native bid looks much weaker.
BTC and ETH perpetual futures volumes on Hyperliquid have fallen to multi-quarter lows, with BTC perp volume around $2B and ETH perp volume around $600M to $700M.
At the same time, equity-linked perps are exploding. Nasdaq 100, S&P 500 and WTI crude contracts generated around $1.3B per day in combined volume and $27.1B notional over the last 30 days, which is equivalent to roughly 112% of Hyperliquid’s ETH perp volume.
Pre-IPO perp volume is also surging, led by SpaceX-style contracts, with daily volume jumping from below $5M to more than $50M.
That is the key point. This does not look like speculative capital disappearing completely. It looks like speculative capital rotating away from crypto and into equity-linked risk.
The Strategy signal added to the pressure. Strategy disclosed a 32 BTC sale, its first net reduction in years, and that clearly damaged sentiment. Bitcoin also recorded more than $584M in trading volume and over 433,000 trades in the nine days through June 4, with trade count rising as price fell. That is not normal calm selling. That is active distribution.
The question now is whether crypto is giving us an early warning, or whether it is simply being abandoned as liquidity chases the equity trade.
The jobs report adds another layer. May payrolls came in at 172,000, far above the 80,000 expected, while unemployment held at 4.3%. That is strong economic data, but it is not automatically bullish for growth stocks.
The 10-year Treasury yield moved back above 4.53% after the print, which tightens financial conditions and pressures long-duration assets. Strong jobs reduce recession risk, but they also reduce the urgency for the Fed to ease.
This matters because tech and crypto were already under pressure. Broadcom dragged semiconductors lower, Bitcoin is on track for its worst week since February, and the Nasdaq has started to cool after a very extended run.
But equities are not falling apart. The Dow just made a fresh record high, and the rotation away from tech is being absorbed by other areas of the market.
Healthcare is the clearest example. Traders bought roughly 5,300 XLV calls versus just over 1,000 puts, and about $11M of the $13M traded in XLV options premium was tied to calls. That is not defensive apathy. That is active bullish positioning in healthcare.
Names like UnitedHealth, Humana, Centene and Eli Lilly are also pushing higher, while financials and other old-economy sectors continue to act better than the most extended tech areas.
So the clean read is this: crypto is warning us that speculative liquidity is under pressure, but the equity market is still absorbing capital.
BTC and ETH are breaking down. Semiconductors are cooling. Yields are rising after a hot jobs print. But healthcare, financials and old-economy leadership are catching flows.
That keeps this as an intra-market rotation for now, not a full risk-off event. Watch BTC and ETH as liquidity tells, watch the 10-year yield above 4.53%, and watch whether healthcare and non-tech leadership continue to absorb capital.
If crypto keeps breaking lower and Nasdaq weakness accelerates, the risk is that rotation turns into broader de-risking. But if equities absorb the crypto sell-off and money keeps rotating into healthcare, financials and lower-beta leadership, the market remains intact.

Nasdaq

QQQ VRVP Daily & Weekly Chart
58.41%: over 20 EMA | 62.37%: over 50 EMA | 58.41%: over 200 EMA
QQQ is still technically holding up well, but the setup is becoming much more fragile in the short-term cycle.
Yesterday’s bounce came on 91% relative volume, and the relative strength rating remains extremely high at 90 versus the SPX. That makes the Nasdaq the strongest major index cohort, which is unsurprising given its exposure to technology, mega-cap growth and AI leadership.

TSLA VRVP Daily & Weekly Chart

GOOGL VRVP Daily & Weekly Chart
We also saw very strong bounces across several key growth names yesterday. GOOGL had an impressive bounce directly from its 50-day moving average and 10-week EMA, which was exactly the bounce play we discussed a few reports ago. For traders who read that analysis and took the setup, that was the correct entry area.
The issue now is not leadership. The issue is extension as the QQQ is still sitting at 8.34 ATR multiples above the 50-day moving average, which means the index remains vulnerable to a short-term pullback. From yesterday’s close, we suspect there is a realistic downside move of roughly 3.87% toward the $711 area.
That level is not random. It is where the visible range volume profile starts to get dense again, and it also lines up with the support structure from the consolidation period between May 11th and May 21st. That was the same area where QQQ built the base before forming the Morning Star reversal between May 18th and May 20th, which then launched the next push higher.
A move into that area would not be a breakdown on the intermediate trend. It would be a short-term-cycle pullback caused by extended positioning.
The Nasdaq remains in a strong primary and intermediate trend, but short-term asymmetry has shifted more toward the downside because of the extension. Since QQQ is the most technically stretched major index, it is also likely to experience the sharpest pullback if the market continues cooling.
This is not the place to take naked long exposure in QQQ. Existing exposure can still be trailed, but fresh long entries should come from pullbacks into support, not from chasing highs.

S&P 400 Midcap

MDY VRVP Daily & Weekly Chart
58.25%: over 20 EMA | 58.75%: over 50 EMA | 57.25%: over 200 EMA
MDY followed through yesterday from its June 2nd breakout, but premarket action is weaker this morning.
We are now gapping down below the strength of yesterday’s candle, and the first key level to watch is around $681.74. That is where the visible range volume profile becomes denser, and it also shows a meaningful buyer imbalance.
At that level, we see roughly 150K shares traded green versus around 98K shares traded red, which suggests buyers are likely to step in if price tests that area.
The bigger level below is around $666. That would represent a sharper pullback of roughly 3.1%, which is realistic over two trading days given MDY’s 1.15% ADR. A move there would also push price back toward the rising 10-week moving average.
At this point in the rally, the daily chart is becoming less useful on its own. We need to give more weight to the weekly structure.
The weekly chart still shows a healthy mid-cap complex. MDY is not as extended as QQQ or SPY, and the broader structure remains intact. Breadth is also still solid, with roughly 58% of stocks above their 20-day through 200-day moving averages.
So while MDY may pull back in the short-term cycle, the intermediate trend still looks constructive.
The key point is that mid-caps remain one of the cleaner areas of the market from an asymmetry standpoint, but the entry now needs to be more patient. We want pullbacks into support, not emotional buying after breakout candles.

Russell 2000

IWM VRVP Daily & Weekly Chart
58.33%: over 20 EMA | 59.91%: over 50 EMA | 59.49%: over 200 EMA
IWM also had a strong session yesterday, bouncing perfectly from the rising 10-day EMA.
The bounce came on 82% relative volume and fully engulfed Friday’s session, which is constructive. That said, the Russell 2000 is still showing exactly the kind of choppy behavior we expected.
The market is indecisive right now. Large-cap technology is extended, crypto is selling off, semiconductors have cooled, and that is creating short-term pressure across risk assets. IWM will not be immune to that.
The key level is $286.60, which is the rising 10-day EMA.If that level fails, we would expect a move lower toward $278.85, where the 50-day moving average and 10-week EMA are clustered. That would be a downside move of roughly 5.31% from yesterday’s close.
That sounds large, but IWM has a much higher average daily range than the other major ETFs, around 1.5%, so larger percentage swings are normal.
The important point is that this would still not necessarily be a breakdown. The Russell 2000 tends to bounce well from the 50-day EMA and 10-week EMA cluster, just like it did on May 19th.
For now, IWM is still structurally healthy, but the short-term cycle is choppy. If $286.60 holds, the bounce remains intact. If it fails, we look for the higher-quality long setup closer to the 50-day and 10-week support zone.

FOCUSED GROUP
XLV: Healthcare is Where The Rotation Is

XLV VRVP Daily & Weekly Chart
Our focused group today is healthcare, and this is where we would be pushing the most attention.
XLV had a very strong breakout yesterday on 140% relative volume, which is a major sign that liquidity is rotating into the group.
The structure is clean. Healthcare has built a large consolidation and double-bottom base between March 27th and May 12th, and it is now expanding higher with volume.
Yesterday’s move was significant. Including the gap, XLV moved roughly 3.5%, which is huge for a healthcare ETF that normally moves around 1.4% per day.
The best part is that healthcare is still not extended. XLV is only sitting around 2.44 ATR multiples above its 50-day moving average, which gives it far better long-side asymmetry than QQQ, semiconductors or the more crowded AI names.

XPH VRVP Daily & Weekly Chart

XBI VRVP Daily & Weekly Chart
This is exactly what we want to see in a rotation trade. Liquidity is clearly moving into healthcare, and the move is being confirmed beneath the surface. XPH, the pharmaceutical ETF, and XBI, the biotech ETF, are both consolidating tightly and bouncing from their rising 20-week moving averages.
Both groups have also formed strong hammer-style weekly candles, which tells us buyers are stepping in aggressively at higher-timeframe support.
From our perspective, healthcare is now one of the most important groups in the market.
As the extended technology and semiconductor trade cools, capital is rotating into areas with cleaner asymmetry. Healthcare has the base, the volume, the breadth improvement and the sector-level confirmation.
This is where we would now look to push aggressive long exposure, especially in the strongest healthcare, biotech and pharmaceutical names breaking out from tight bases.

Did you find value in today's publication?This helps us better design our content for our readers |
Reply